On April 2, 2019, the Georgia General Assembly passed House Bill 324 titled "Georgia's Hope Act," which authorizes the Georgia Access to Medical Cannabis Commission to oversee the regulated licensing of limited, in-state cultivation, production, manufacturing, and sale of low-THC oil as well as dispensing to registered patients on the state's Low-THC Oil Registry. Governor Kemp signed the bill into law on April 17, 2019. Georgia's Hope Act (Official Code of Georgia Annotated §16-12) took effect July 1, 2019. The Commission is administratively attached (O.C. G. A. § 16-12-202, § 50-4-3) to the Office of the Georgia Secretary of State.

The first Commission Members were appointed in November, 2019. Seven Members serve on the Commission: the Chair and two Members are appointed by the Governor, two Members are appointed by the Lieutenant Governor, and two Members appointed by the Speaker of the House. The Commission was appropriated funds as a new State of Georgia government agency by the Georgia General Assembly in 2019. The Commission selected from four candidates vetted by The Goodwin Group, a national search firm, and appointed an Executive Director in May, 2020.

• History of the Medical Cannabis Commission
• Rules and Georgia Law
• Patient information
  • Georgia Department of Public Health
  • Low-THC Oil Patient Registry
  • Licensed Dispensaries
• Visit Georgia Access to Medical Cannabis Commission